Amyloid-β-induced alteration of fast and localized calcium elevations in cultured astrocytes
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that causes cognitive decline. Uncovering the mechanisms of neurodegeneration in the early stages is essential to establish a treatment for AD. Recent research has proposed the hypothesis that amyloid-β (Aβ) oligomers elicit an excessive glutamate release from astrocytes toward synapses through intracellular free Ca<sup>2+</sup> ([Ca<sup>2+</sup>]<sub>i</sub>) elevations in astrocytes, finally resulting in neuronal dendritic spine loss. Under physiological conditions, astrocytic [Ca<sup>2+</sup>]<sub>i</sub> elevations range spatially from microdomains to network-wide propagation and temporally from milliseconds to tens of seconds. Astrocytic localized and fast [Ca<sup>2+</sup>]<sub>i</sub> elevations might correlate with glutamate release; however, the Aβ-induced alteration of localized, fast astrocytic [Ca<sup>2+</sup>]<sub>i</sub> elevations remains unexplored. In this study, we quantitatively investigated the Aβ dimers-induced changes in the spatial and temporal patterns of [Ca<sup>2+</sup>]<sub>i</sub> in a primary culture of astrocytes by two-photon excitation spinning-disk confocal microscopy. The frequency of fast [Ca<sup>2+</sup>]<sub>i</sub> elevations occurring locally in astrocytes (≤ 0.5 s, ≤ 35 µm<sup>2</sup>) and [Ca<sup>2+</sup>]<sub>i</sub> event occupancy relative to cell area significantly increased after exposure to Aβ dimers. The effect of Aβ dimers appeared above 500 nM, and these Aβ dimers-induced [Ca<sup>2+</sup>]<sub>i</sub> elevations were primarily mediated by a metabotropic purinergic receptor (P2Y1 receptor) and Ca<sup>2+</sup> release from the endoplasmic reticulum. Our findings suggest that the Aβ dimers-induced alterations and hyperactivation of astrocytic [Ca<sup>2+</sup>]<sub>i</sub> is a candidate cellular mechanism in the early stages of AD.
Authors
- Kohei Otomo (ORCID: https://orcid.org/0000-0002-5322-6295)
- Masanao Sato (ORCID: https://orcid.org/0000-0003-3790-8218)
- Kaito Nakata (ORCID: https://orcid.org/0000-0001-5876-3279)
- Tomomi Nemoto (ORCID: https://orcid.org/0000-0001-6102-1495)
- Motosuke Tsutsumi (ORCID: https://orcid.org/0000-0002-5832-3828)
- Hirokazu Ishii (ORCID: https://orcid.org/0000-0001-8391-194X)
- Ryosuke Enoki (ORCID: https://orcid.org/0000-0002-0546-0167)
- Joe Sakamoto (ORCID: https://orcid.org/0000-0003-2295-0659)
Institutions
- National Institutes of Natural Sciences (JP)
- The Graduate University for Advanced Studies, SOKENDAI (JP)
- Hokkaido University (JP)
- Juntendo University (JP)
Publication Details
- Journal
- Scientific Reports
- Published
- 2025-05-29
- DOI
- https://doi.org/10.1038/s41598-025-03931-7
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Agency for Medical Research and Development
- Ministry of Education, Culture, Sports, Science and Technology
- Jikei University School of Medicine
- Japan Society for the Promotion of Science
- Japan Science and Technology Agency
- National Institutes of Natural Sciences
- Core Research for Evolutional Science and Technology
- Exploratory Research Center on Life and Living Systems, National Institutes of Natural Sciences